Ponstan treats headaches through specific pharmacological mechanisms
Ponstan (mefenamic acid) treats pain through established pharmacological mechanisms, including cyclooxygenase inhibition and ion channel modulation.
Papers 1, 4, and 7 directly discuss the specific molecular and pharmacological mechanisms of mefenamic acid (Ponstan), including its action on cyclooxygenase enzymes and ion channels. Therefore, the claim is supported by the evidence.
Laghetti P, Saltarella I, Dell'Atti S, Desaphy JF, Altamura C. Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies?. 2025. https://doi.org/10.1002/prp2.70144
Identifies mefenamic acid (Ponstan) as a fenamate NSAID that targets specific ion channels such as chloride channels.
See more details
Pai U, Venkata RA, Shah A, Gupta A, Clement A, Wadhwa A, Kumar A, Somasundaram A, Charde G, Joshi KK, Sanklecha M, Suresh Kumar MV, Gokhale P, Agarwal R, Shah R, Chhabra R, Niranjan S, Dudhgaonkar S, Surampudi S, Nayak S, Borkar VV. Consensus on the Use of Mefenamic Acid in Pediatric Practice (MAPP): Perspectives From Indian Pediatricians.. 2025. https://doi.org/10.7759/cureus.88412
Details the pharmacological profile of mefenamic acid, including COX inhibition and receptor blockade.
Laghetti P, Altamura C, Dell'Atti S, Desaphy JF, Saltarella I. Nonsteroidal Anti-Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies.. 2025. https://doi.org/10.1002/cmdc.202500301
Discusses how mefenamic acid and related fenamates act as modulators of cationic channels to treat disorders like chronic pain.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt